297 related articles for article (PubMed ID: 19092468)
1. Physician beliefs and behaviors related to glaucoma treatment adherence: the Glaucoma Adherence and Persistency Study.
Gelb L; Friedman DS; Quigley HA; Lyon DW; Tan J; Kim EE; Zimmerman TJ; Hahn SR
J Glaucoma; 2008 Dec; 17(8):690-8. PubMed ID: 19092468
[TBL] [Abstract][Full Text] [Related]
2. Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study.
Friedman DS; Hahn SR; Gelb L; Tan J; Shah SN; Kim EE; Zimmerman TJ; Quigley HA
Ophthalmology; 2008 Aug; 115(8):1320-7, 1327.e1-3. PubMed ID: 18321582
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study.
Quigley HA; Friedman DS; Hahn SR
Ophthalmology; 2007 Sep; 114(9):1599-606. PubMed ID: 17572498
[TBL] [Abstract][Full Text] [Related]
4. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS).
Friedman DS; Quigley HA; Gelb L; Tan J; Margolis J; Shah SN; Kim EE; Zimmerman T; Hahn SR
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5052-7. PubMed ID: 17962457
[TBL] [Abstract][Full Text] [Related]
5. Use of glaucoma medications: state of the science and directions for observational research.
Lu VH; Goldberg I; Lu CY
Am J Ophthalmol; 2010 Oct; 150(4):569-574.e9. PubMed ID: 20678750
[TBL] [Abstract][Full Text] [Related]
6. Rates of glaucoma medication utilization among persons with primary open-angle glaucoma, 1992 to 2002.
Stein JD; Ayyagari P; Sloan FA; Lee PP
Ophthalmology; 2008 Aug; 115(8):1315-9, 1319.e1. PubMed ID: 18321581
[TBL] [Abstract][Full Text] [Related]
7. Persistence and adherence with topical glaucoma therapy.
Nordstrom BL; Friedman DS; Mozaffari E; Quigley HA; Walker AM
Am J Ophthalmol; 2005 Oct; 140(4):598-606. PubMed ID: 16226511
[TBL] [Abstract][Full Text] [Related]
8. Patients' and physicians' perceptions of the travoprost dosing aid: an open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension.
Flowers B; Wand M; Piltz-Seymour J; Berke SJ; Day D; Teague J; Smoot TM; Landry TA; Bergamini MV; Mallick S;
Clin Ther; 2006 Nov; 28(11):1803-11. PubMed ID: 17213000
[TBL] [Abstract][Full Text] [Related]
9. Gathering evidence from claims data: caveats.
Coleman AL
Ophthalmology; 2007 Sep; 114(9):1597-8. PubMed ID: 17822970
[No Abstract] [Full Text] [Related]
10. Adherence and persistence with glaucoma therapy.
Schwartz GF; Quigley HA
Surv Ophthalmol; 2008 Nov; 53 Suppl1():S57-68. PubMed ID: 19038625
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive perspective on patient adherence to topical glaucoma therapy.
Tsai JC
Ophthalmology; 2009 Nov; 116(11 Suppl):S30-6. PubMed ID: 19837258
[TBL] [Abstract][Full Text] [Related]
12. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
[TBL] [Abstract][Full Text] [Related]
13. Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma.
Rees G; Leong O; Crowston JG; Lamoureux EL
Ophthalmology; 2010 May; 117(5):903-8. PubMed ID: 20153902
[TBL] [Abstract][Full Text] [Related]
14. [Compliance and ignorance in glaucoma in Romanian patients].
Dumitrica DM; Stefan C
Oftalmologia; 2009; 53(3):130-3. PubMed ID: 19899560
[TBL] [Abstract][Full Text] [Related]
15. Determinants of adherence to glaucoma medical therapy in a long-term patient population.
Djafari F; Lesk MR; Harasymowycz PJ; Desjardins D; Lachaine J
J Glaucoma; 2009 Mar; 18(3):238-43. PubMed ID: 19295380
[TBL] [Abstract][Full Text] [Related]
16. Effect of patient-centered communication training on discussion and detection of nonadherence in glaucoma.
Hahn SR; Friedman DS; Quigley HA; Kotak S; Kim E; Onofrey M; Eagan C; Mardekian J
Ophthalmology; 2010 Jul; 117(7):1339-47.e6. PubMed ID: 20207417
[TBL] [Abstract][Full Text] [Related]
17. Health literacy and adherence to glaucoma therapy.
Muir KW; Santiago-Turla C; Stinnett SS; Herndon LW; Allingham RR; Challa P; Lee PP
Am J Ophthalmol; 2006 Aug; 142(2):223-6. PubMed ID: 16876500
[TBL] [Abstract][Full Text] [Related]
18. Patient-centered communication to assess and enhance patient adherence to glaucoma medication.
Hahn SR
Ophthalmology; 2009 Nov; 116(11 Suppl):S37-42. PubMed ID: 19837259
[TBL] [Abstract][Full Text] [Related]
19. Doctor-patient communication in glaucoma care: analysis of videotaped encounters in community-based office practice.
Friedman DS; Hahn SR; Quigley HA; Kotak S; Kim E; Onofrey M; Eagan C; Mardekian J
Ophthalmology; 2009 Dec; 116(12):2277-85.e1-3. PubMed ID: 19744715
[TBL] [Abstract][Full Text] [Related]
20. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.
El-Serag HB; Fitzgerald S; Richardson P
Am J Gastroenterol; 2009 Sep; 104(9):2161-7. PubMed ID: 19568229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
